Sort
130,381 grants matching “hiv”
HIV PREVENTION AND CARE SERVICES FOR YOUNG PEOPLE IN KENYA
$1,230,325Allan Ragi · Kenya Aids Ngos Consortium (Kanco) · U62 · FY2009 · PS
IND-enabling toxicology studies to reach IND approval for a proprietary biologic to treat oral mucositis in cancer patients
$1,230,285Christian Young · Allander Biotechnologies, Inc. · SB1 · FY2024 · DE
Technology-based Treatmentsfor Substance Use Disorders
$1,230,249Lisa A Marsch · Dartmouth College · P30 · FY2018 · DA
Molecular Epidemiology of non Hodgkin's Lymphoma
$1,230,182University Of California San Francisco · R01 · FY2005 · CA
IMPLEMENTATION & EXPANSION OF HIGH QUALITY HIV CARE, PREVENTION & TREATMENT
$1,230,000Paul Wekesa · Centre For Health Solutions · U2G · FY2012 · GH
Clinical Trial Unit for HIV Prevention and Microbicide Research
$1,229,912Kenneth H Mayer · Fenway Community Health Center · UM1 · FY2012 · AI
An unbiased OMICs approach to identify mechanisms of Cocaine regulation of the HIV reservoir.
$1,229,898Rafick-Pierre Sekaly · Case Western Reserve University · R01 · FY2016 · DA
Phase 2 Pharmacodynamic Study of High-dose Levofloxacin in MDR-TB Treatment
$1,229,745C Robert Horsburgh · Boston University Medical Campus · U01 · FY2016 · AI
Interactions Of Human Immunodeficiency Virus With Receptors
$1,229,727Edward Berger · Niaid Extramural Activities · Z01 · FY2007 · AI
Resource for Native Mass Spectrometry Guided Structural Biology
$1,229,682Vicki H Wysocki · Ohio State University · P41 · FY2019 · GM
High-Throughput Nanoloter Crystallization Facility
$1,229,450Douglas H Ohlendorf · University Of Minnesota · S10 · FY2008 · RR
Resource for Native Mass Spectrometry Guided Structural Biology
$1,229,448Vicki H Wysocki · Ohio State University · P41 · FY2020 · GM
HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-Targeted HAART
$1,229,392Ronald J. Ellis · University Of California, San Diego · R01 · FY2008 · MH
Product Development and Manufacture
$1,229,292Robert T McNally · Geovax, Inc. · U19 · FY2008 · AI
Resource for Native Mass Spectrometry Guided Structural Biology
$1,229,201Vicki H Wysocki · Ohio State University · P41 · FY2021 · GM
PR COMPREHENSIVE CTR FOR HIV DISPARITIES:UPR:FACULTY DVMT & CLIN BEHV RES CORES
$1,229,023Carmen D Zorrilla · University Of Puerto Rico Med Sciences · U54 · FY2008 · RR
Mexican Family Culture & Substance Use Risk & Resilience
$1,229,005Richard W Robins · University Of California At Davis · R01 · FY2012 · DA
Resource for Native Mass Spectrometry Guided Structural Biology
$1,228,939Vicki H Wysocki · Ohio State University · P41 · FY2022 · GM
Effect of Microbicides on Mucosal HIV Transmission
$1,228,872University Of California Davis · R01 · FY2004 · AI
Center on Intersystem Regulation by Drugs of Abuse
$1,228,730Ellen M Unterwald · Temple Univ Of The Commonwealth · P30 · FY2014 · DA
Dose flexible ultra-long-acting prodrug formulations for pediatric populations
$1,228,661Benson Edagwa · University Of Nebraska Medical Center · R61 · FY2025 · AI
Dynamics of HIV Core Interactions
$1,228,602Stefan G Sarafianos · Seattle Children'S Hospital · U54 · FY2022 · AI
Penn prevention clinical trials unit
$1,228,585David S Metzger · University Of Pennsylvania · U01 · FY2007 · AI
Env evolution in humans and RMs
$1,228,300George M Shaw · University Of Pennsylvania · P01 · FY2017 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,227,954University Of Pittsburgh At Pittsburgh · U01 · FY2001 · AI